These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 498168)

  • 1. Allopurinol modulation of high-dose fluorouracil toxicity.
    Fox RM; Woods RL; Tattersall HN; Brodie GW
    Cancer Treat Rev; 1979 Jun; 6 Suppl():143-7. PubMed ID: 498168
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol modulation of high-dose fluorouracil toxicity.
    Fox RM; Woods RL; Tattersall MH; Brodie GM
    Lancet; 1979 Mar; 1(8117):677. PubMed ID: 85922
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of 5-fluorouracil-induced stomatitis by allopurinol mouthwashes.
    Elzawawy A
    Oncology; 1991; 48(4):282-4. PubMed ID: 1891169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of oral toxicity of 5-fluorouracil by allopurinol mouthwashes.
    Tsavaris N; Caragiauris P; Kosmidis P
    Eur J Surg Oncol; 1988 Oct; 14(5):405-6. PubMed ID: 3181443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol modulation of fluorouracil toxicity.
    Fox RM; Woods RL; Tattersall MH; Piper AA; Sampson D
    Cancer Chemother Pharmacol; 1981; 5(3):151-5. PubMed ID: 6457698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of fluorouracil. A preliminary trial.
    Nadler SH
    Arch Surg; 1968 Oct; 97(4):654-6. PubMed ID: 5678137
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ; Moertel CG; Hahn RG
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract]   [Full Text] [Related]  

  • 8. Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil.
    Schwartz PM; Dunigan JM; Marsh JC; Handschumacher RE
    Cancer Res; 1980 Jun; 40(6):1885-9. PubMed ID: 7371020
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-fluorouracil intravenous infusion for 48 hours, repeated every two weeks.
    Hill GJ; Grage TB; Wilson W; Ansfield FJ
    J Surg Oncol; 1972; 4(1):60-70. PubMed ID: 5033956
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of 5-fluorouracil toxicity by allopurinol in man.
    Howell SB; Wung WE; Taetle R; Hussain F; Romine JS
    Cancer; 1981 Sep; 48(6):1281-9. PubMed ID: 7023652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer.
    Lokich JJ; Pitman SW; Skarin AT
    Oncology; 1975; 32(1):34-7. PubMed ID: 1208028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective antagonism of 5-fluorouracil cytotoxicity by 4-hydroxypyrazolopyrimidine (allopurinol) in vitro.
    Schwartz PM; Handschumacher RE
    Cancer Res; 1979 Aug; 39(8):3095-101. PubMed ID: 455294
    [No Abstract]   [Full Text] [Related]  

  • 13. Allopurinol modulation of high-dose fluorouracil toxicity.
    Tisman G; Wu SJ
    Lancet; 1979 Jun; 1(8130):1353-4. PubMed ID: 87818
    [No Abstract]   [Full Text] [Related]  

  • 14. Allopurinol mouthwashes and 5-fluorouracil induced oral toxicity.
    Clark PI; Slevin ML
    Eur J Surg Oncol; 1985 Sep; 11(3):267-8. PubMed ID: 4029407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
    Smith BJ; Ashford RF; Bakowski M; Hellman K; Newton K; Phillips R; Lambert J; Jones R; Peters N; Evans M
    Am J Clin Oncol; 1983 Aug; 6(4):481-4. PubMed ID: 6346856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis.
    Van der Vliet W; Erlichman C; Elhakim T
    Clin Pharm; 1989 Sep; 8(9):655-8. PubMed ID: 2791481
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 18. Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis.
    Yokomizo H; Yoshimatsu K; Hashimoto M; Ishibashi K; Umehara A; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Anticancer Res; 2004; 24(2C):1131-4. PubMed ID: 15154636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-fluorouracil with cytosine arabinoside in metastatic gastrointestinal cancer.
    Muss HB; Lokich JJ; Frei E
    Clin Pharmacol Ther; 1975 Aug; 18(2):234-7. PubMed ID: 1149369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of combined therapy with 5-FU (NSC 19893) and CIS-platinum (II) diaminedichloride (NSC 119875).
    Ellerby RA; Davis HL; Ansfield FJ; Ramirez G
    Cancer; 1974 Oct; 34(4):1005-10. PubMed ID: 4607883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.